Biolaxy Secures IND Approval For Oral Insulin

Biolaxy Secures IND Approval For Oral Insulin

SHANGHAI, November 24 /PRNewswire/ -- Shanghai Biolaxy announced the Chinese State Food Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin…
US Patent Allowed For NOD Tech

US Patent Allowed For NOD Tech

SHANGHAI, November 24 /PRNewswire/ -- NOD Pharmaceuticals Inc. announced the US Patent Trademark Office (PTO) has allowed the patent application for its nano-particle oral delivery or NOD technology…